Abstract:B cells arise from the bone marrow and differentiate into various functional subsets in the peripheral lymphoid organs and inflammatory sites. Whereas T cells have been recognized as the dominant immune population in the tumor microenvironment, increasing evidence has shown the involvement of B cells in cancer development [1]. Within tertiary lymphoid structures (TLSs), which consist of aggregates of spatially organized immune cells in tumors, B cells actively interact with other populations and promote immunotherapy responses [1, 2]. However, the cellular heterogeneity, functional diversity, and underlying mechanisms of B-cell subsets across diverse cancer types remain major challenges for dissecting the roles of B cells in tumor development and immunotherapies. In newly published papers in Science and Cell , two research groups independently established pancancer landscapes of tumor-infiltrating B cells across major human cancer types by integrating single-cell transcriptomes, B-cell-receptor (BCR) repertoires, chromatin accessibility data, and clinical prognostic information [3, 4]. Using public datasets and their generated single-cell RNA sequencing (scRNA-seq) data derived from cancer patients, Ma et al. identified 15 distinct B-cell subsets, whereas Yang et al. discovered a total of 20 fine-grained B-cell subpopulations, both of which showed significant tissue and cancer-type preferences. These two studies successfully characterized major B-cell subsets during different maturation stages, including naïve B cells, pre-germinal center and germinal center (GC)B cells, memory B cells, and plasma cells, on the basis of their hallmark gene expression signatures. Notably, they revealed the molecular phenotypes and functional features of novel B-cell subsets, including stressed B cells and tumor-associated atypical B (TAAB) cells, across cancer types. These novel findings revealed the existence of diverse functional B-cell subsets at the pancancer level and their associations with the clinical prognosis of cancer patients.

Role of B cells as antigen presenting cells

New insights into B cells as antigen presenting cells

The role of B lymphocytes as antigen-presenting cells

An Overview of B-1 Cells as Antigen-Presenting Cells

B-cell Receptor Repertoire Sequencing: Deeper Digging into the Mechanisms and Clinical Aspects of Immune-Mediated Diseases

Participation of B cell in immunotherapy of cancer

Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade

Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis

Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells

The Role of B Cells in Solid Tumors

B Cells in Primitive Vertebrate Act As Pivotal Antigen Presenting Cells in Priming Adaptive Immunity (P5035)

MHC cross-dressing in antigen presentation

Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

The Emerging Role of B Cells in Tumor Immunity.

Both sides now: evolutionary traits of antigens and B cells in tolerance and activation

B cells: The many facets of B cells in allergic diseases

B Cells in Autoimmune Diseases

Basophils control T cell priming through soluble mediators rather than antigen presentation

Antibody-independent functions of B cells during viral infections

The emerging roles of B cells in cancer development

B Cell Activation and Autoantibody Production in Autoimmune Diseases.